ERIN Summit Brought Together Patients and Their Families, Offering a Space to Learn, Connect, Feel Supported
EHC – European Haemophilia Consortium shared a post on LinkedIn:
“From 5 to 7 December, we proudly hosted the ERIN Summit in Berlin, Germany. This annual event brings together patients with extremely rare bleeding disorders and their families, offering a unique, family-friendly space to learn, connect, and feel supported.
This year’s programme focused on treatment updates, unmet needs, and lived experiences. Through open discussions and interactive workshops, we strengthened knowledge within the community and built a foundation for continued learning and collaboration.

The tradition of the ERIN summit reflects a long-standing dedication to empowering this community with practical information and advocacy tools. A heartfelt thank-you goes to the ERIN Committee for their ongoing commitment to making patients with extremely rare bleeding disorders more visible and heard. By sharing knowledge and amplifying patient stories, we aim to ensure no one is left behind!
Learn more about the EHC ERIN here”
Get the latest updates with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy
